Lavipharm (ATH:LAVI) Cash And Cash Equivalents : €8.69 Mil (As of Jun. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Lavipharm Cash And Cash Equivalents?

Lavipharm's quarterly cash and cash equivalents declined from Jun. 2023 (€14.41 Mil) to Dec. 2023 (€8.44 Mil) but then increased from Dec. 2023 (€8.44 Mil) to Jun. 2024 (€8.69 Mil).

Lavipharm's annual cash and cash equivalents increased from Dec. 2021 (€1.64 Mil) to Dec. 2022 (€18.24 Mil) but then declined from Dec. 2022 (€18.24 Mil) to Dec. 2023 (€8.44 Mil).

Lavipharm Cash And Cash Equivalents Historical Data

The historical data trend for Lavipharm's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lavipharm Cash And Cash Equivalents Chart

Lavipharm Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

1.73

1.93

1.64

18.24

8.44

Lavipharm Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Cash And Cash Equivalents	Get a 7-Day Free Trial						2.74	18.24	14.41	8.44	8.69

Lavipharm Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Lavipharm (ATH:LAVI) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Lavipharm Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Lavipharm's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Lavipharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (ATH:LAVI) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

BXA0:Germany

Address

Agias Marinas Street, PO Box 59, Peania Attica, GRC, 19002

Website

http://www.lavipharm.com

Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Lavipharm Headlines

No Headlines